ENTBFENTHEON BIOMEDICAL CORP.

About ENTHEON BIOMEDICAL CORP. (ENTBF)

ENTHEON BIOMEDICAL CORP. (ENTBF) is a Biotechnology company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the OTCQB tier.

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.

Products and services

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.

ENTBF key facts

Ticker symbol

ENTBF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2010

Employees

4

Estimated market cap

$1.10M (as of Apr 11, 2025)

Shares outstanding

13,858,934

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

11/30

Latest filing

Quarterly Report (Feb 28, 2025)

ENTHEON BIOMEDICAL CORP. leadership

• Timothy Ko — CEO
• Soo-Whan Kim — Acting CFO
• Kelly Young Pladson — Corporate Secretary

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with E